186 related articles for article (PubMed ID: 16634536)
21. The surgical management of rhinocerebral mucormycosis.
Abu El-Naaj I; Leiser Y; Wolff A; Peled M
J Craniomaxillofac Surg; 2013 Jun; 41(4):291-5. PubMed ID: 23058177
[TBL] [Abstract][Full Text] [Related]
22. Combination antifungal therapy for invasive aspergillosis.
Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
[TBL] [Abstract][Full Text] [Related]
23. [Efficacies and clinical roles of new antifungal agents].
Tokimatsu I; Kadota J
Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):155-9. PubMed ID: 16940948
[TBL] [Abstract][Full Text] [Related]
24. Combination antifungal therapy for invasive aspergillosis.
Cesaro S; Visintin G
Clin Infect Dis; 2005 Apr; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
[No Abstract] [Full Text] [Related]
25. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Chirch L; Roche P; Fuhrer J
Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
[TBL] [Abstract][Full Text] [Related]
26. Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Steinbach WJ
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):203-10. PubMed ID: 16181140
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
MacCallum DM; Whyte JA; Odds FC
Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
30. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
van Vianen W; de Marie S; ten Kate MT; Mathot RA; Bakker-Woudenberg IA
J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
[TBL] [Abstract][Full Text] [Related]
31. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of three patients with intracranially invasive sino-orbital aspergillosis.
Yoon JS; Park HK; Cho NH; Lee SY
Ophthalmic Plast Reconstr Surg; 2007; 23(5):400-6. PubMed ID: 17881994
[TBL] [Abstract][Full Text] [Related]
33. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
34. [Sino-nasal endoscopic surgery in fungal sinusitis. Our experience].
Alobid I; Bernal M; Menéndez LM; Alós L; Benítez P; Cardesa A; Mullol J
Acta Otorrinolaringol Esp; 2002; 53(6):393-7. PubMed ID: 12402488
[TBL] [Abstract][Full Text] [Related]
35. Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
Shlobin OA; Dropulic LK; Orens JB; Mcdyer JF; Conte JV; Yang SY; Girgis R
J Heart Lung Transplant; 2005 Nov; 24(11):1991-4. PubMed ID: 16297812
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S
Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Verma A; Williams S; Trifilio S; Zembower T; Mehta J
Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
[No Abstract] [Full Text] [Related]
38. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Fincher T; Fulcher SF
Cornea; 2007 Jun; 26(5):618-20. PubMed ID: 17525663
[TBL] [Abstract][Full Text] [Related]
39. Disseminated invasive aspergillosis in a patient with acute leukaemia.
Gottfredsson M; Steingrímsdóttir H
Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
[TBL] [Abstract][Full Text] [Related]
40. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]